Population bottlenecks and founder effects: implications for mosquito-borne arboviral emergence.


Journal

Nature reviews. Microbiology
ISSN: 1740-1534
Titre abrégé: Nat Rev Microbiol
Pays: England
ID NLM: 101190261

Informations de publication

Date de publication:
03 2021
Historique:
accepted: 03 11 2020
pubmed: 13 1 2021
medline: 14 4 2021
entrez: 12 1 2021
Statut: ppublish

Résumé

Transmission of arthropod-borne viruses (arboviruses) involves infection and replication in both arthropod vectors and vertebrate hosts. Nearly all arboviruses are RNA viruses with high mutation frequencies, which leaves them vulnerable to genetic drift and fitness losses owing to population bottlenecks during vector infection, dissemination from the midgut to the salivary glands and transmission to the vertebrate host. However, despite these bottlenecks, they seem to avoid fitness declines that can result from Muller's ratchet. In addition, founder effects that occur during the geographic introductions of human-amplified arboviruses, including chikungunya virus and Zika virus, can affect epidemic and endemic circulation, as well as virulence. In this Review, we discuss the role of genetic drift following population bottlenecks and founder effects in arboviral evolution and spread, and the emergence of human disease.

Identifiants

pubmed: 33432235
doi: 10.1038/s41579-020-00482-8
pii: 10.1038/s41579-020-00482-8
pmc: PMC7798019
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

184-195

Subventions

Organisme : NIAID NIH HHS
ID : R01 AI121452
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI145918
Pays : United States
Organisme : NIAID NIH HHS
ID : R24 AI120942
Pays : United States

Références

mBio. 2018 Mar 6;9(2):
pubmed: 29511072
Proc Natl Acad Sci U S A. 1992 Jul 1;89(13):6015-9
pubmed: 1321432
Virology. 2008 Mar 1;372(1):176-86
pubmed: 18023837
Proc Natl Acad Sci U S A. 2020 Aug 18;117(33):20190-20197
pubmed: 32747564
Am J Trop Med Hyg. 2015 Dec;93(6):1325-9
pubmed: 26416113
PLoS Negl Trop Dis. 2018 Oct 4;12(10):e0006827
pubmed: 30286095
PLoS Pathog. 2019 Apr 4;15(4):e1007610
pubmed: 30947291
Lancet Infect Dis. 2017 Mar;17(3):330-338
pubmed: 28017559
Lancet. 2014 Feb 8;383(9916):514
pubmed: 24506907
Adv Virus Res. 2017;98:119-146
pubmed: 28433051
Infect Genet Evol. 2009 Jul;9(4):523-40
pubmed: 19460319
Mol Biol Evol. 2018 Jun 1;35(6):1547-1549
pubmed: 29722887
Med J Malaysia. 2007 Aug;62(3):214-7
pubmed: 18246910
PLoS Negl Trop Dis. 2019 Jan 17;13(1):e0006919
pubmed: 30653504
Virus Evol. 2018 Feb 15;4(1):vey001
pubmed: 29479479
Cell Host Microbe. 2016 Apr 13;19(4):481-92
pubmed: 27049584
PLoS Negl Trop Dis. 2017 Jul 3;11(7):e0005683
pubmed: 28672006
Nat Commun. 2021 Jan 26;12(1):595
pubmed: 33500409
Virol J. 2008 Feb 27;5:33
pubmed: 18304328
Annu Rev Med. 2018 Jan 29;69:395-408
pubmed: 28846489
Am J Trop Med Hyg. 2018 Feb;98(2):432-444
pubmed: 29280428
Annu Rev Virol. 2014 Nov;1(1):71-88
pubmed: 26958715
Euro Surveill. 2014 Apr 03;19(13):
pubmed: 24721536
Annu Rev Entomol. 2020 Jan 7;65:313-332
pubmed: 31594410
Virology. 2007 Feb 20;358(2):402-12
pubmed: 17014880
Curr Opin Virol. 2016 Feb;16:143-150
pubmed: 26986235
Antiviral Res. 2017 Aug;144:223-246
pubmed: 28595824
Am J Trop Med Hyg. 2017 Aug;97(2):330-339
pubmed: 28829735
PLoS One. 2007 Nov 14;2(11):e1168
pubmed: 18000540
Parasit Vectors. 2020 Apr 7;13(1):178
pubmed: 32264941
Emerg Microbes Infect. 2018 Nov 15;7(1):181
pubmed: 30429457
PLoS Pathog. 2011 Nov;7(11):e1002335
pubmed: 22102808
Lancet. 2007 Dec 1;370(9602):1840-6
pubmed: 18061059
Proc Natl Acad Sci U S A. 2004 Aug 3;101(31):11344-9
pubmed: 15277679
PLoS Negl Trop Dis. 2017 Sep 29;11(9):e0005976
pubmed: 28961239
Nat Rev Microbiol. 2010 Dec;8(12 Suppl):S7-16
pubmed: 21079655
Parasit Vectors. 2017 Aug 31;10(1):406
pubmed: 28859676
PLoS Pathog. 2018 Jun 7;14(6):e1006979
pubmed: 29879219
PLoS Pathog. 2012 Sep;8(9):e1002897
pubmed: 23028310
PLoS Med. 2006 Jul;3(7):e263
pubmed: 16700631
Viruses. 2014 Oct 23;6(10):3991-4004
pubmed: 25341663
PLoS Genet. 2016 Jun 15;12(6):e1006111
pubmed: 27304978
Int J Infect Dis. 2020 Mar;92:189-196
pubmed: 31935537
J Virol. 2004 Nov;78(21):11605-14
pubmed: 15479801
Science. 2016 Apr 15;352(6283):345-349
pubmed: 27013429
Am J Trop Med Hyg. 1969 May;18(3):411-5
pubmed: 4976739
Nature. 2013 Apr 25;496(7446):504-7
pubmed: 23563266
J Virol. 2014 Aug;88(16):9260-7
pubmed: 24899192
N Engl J Med. 2017 Apr 13;376(15):1397-1399
pubmed: 28273000
Science. 1999 Dec 17;286(5448):2333-7
pubmed: 10600742
PLoS Pathog. 2007 Dec;3(12):e201
pubmed: 18069894
Viruses. 2015 Jul 08;7(7):3741-67
pubmed: 26184281
PLoS Negl Trop Dis. 2012;6(4):e1606
pubmed: 22509419
PLoS Negl Trop Dis. 2018 Oct 24;12(10):e0006886
pubmed: 30356234
Viruses. 2019 Nov 18;11(11):
pubmed: 31752097
J Virol. 1999 May;73(5):4316-26
pubmed: 10196330
J Virol. 2016 Nov 14;90(23):10600-10611
pubmed: 27654297
Virus Evol. 2017 Nov 06;3(2):vex031
pubmed: 29497564
J Gen Virol. 2000 Feb;81(Pt 2):471-9
pubmed: 10644846
Virology. 2018 Jun 20;521:138-148
pubmed: 29935423
PLoS Pathog. 2017 May 5;13(5):e1006365
pubmed: 28475646
Proc Natl Acad Sci U S A. 2011 May 10;108(19):7872-7
pubmed: 21518887
Am J Trop Med Hyg. 2008 Apr;78(4):681-6
pubmed: 18385369
Emerg Infect Dis. 2008 Aug;14(8):1232-9
pubmed: 18680646
Nature. 2017 Jun 15;546(7658):406-410
pubmed: 28538727
Nat Microbiol. 2019 May;4(5):854-863
pubmed: 30833735
PLoS One. 2019 Jul 16;14(7):e0219553
pubmed: 31310645
Nature. 2017 May 25;545(7655):482-486
pubmed: 28514450
BMC Med. 2015 Apr 30;13:102
pubmed: 25976325
Arch Virol Suppl. 2005;(19):33-44
pubmed: 16358422
PLoS Negl Trop Dis. 2016 Dec 28;10(12):e0005189
pubmed: 28030537
Euro Surveill. 2017 Sep;22(39):
pubmed: 29019306
Curr Biol. 2020 Sep 21;30(18):3495-3506.e6
pubmed: 32679098
Curr Top Microbiol Immunol. 1992;176:99-117
pubmed: 1318187
Am J Trop Med Hyg. 2007 Mar;76(3):405-7
pubmed: 17360859
Cell Rep. 2017 Apr 25;19(4):709-718
pubmed: 28445723
Am J Trop Med Hyg. 2017 Nov;97(5):1410-1417
pubmed: 28820694
Proc Natl Acad Sci U S A. 2008 May 13;105(19):6970-5
pubmed: 18458341
Virology. 2013 Jan 20;435(2):406-14
pubmed: 23099205
Emerg Microbes Infect. 2019;8(1):242-244
pubmed: 30866777
Tissue Cell. 1990;22(6):895-909
pubmed: 1982591
PLoS Negl Trop Dis. 2015 Sep 01;9(9):e0004052
pubmed: 26325059
Mutat Res. 1964 May;106:2-9
pubmed: 14195748
Emerg Infect Dis. 2006 Aug;12(8):1190-6
pubmed: 16965696
Nat Commun. 2014 Jun 16;5:4084
pubmed: 24933611
PLoS Pathog. 2018 Mar 28;14(3):e1006964
pubmed: 29590202
PLoS Negl Trop Dis. 2019 May 16;13(5):e0007332
pubmed: 31095561
PLoS Negl Trop Dis. 2015 May 07;9(5):e0003764
pubmed: 25951202
Bioessays. 2008 May;30(5):470-9
pubmed: 18404703
J Virol. 1988 Jun;62(6):2083-90
pubmed: 2896802
PLoS One. 2009 Jun 12;4(6):e5895
pubmed: 19521520
Clin Microbiol Rev. 2016 Jul;29(3):487-524
pubmed: 27029595
PLoS Negl Trop Dis. 2014 Feb 06;8(2):e2681
pubmed: 24516683
Proc Natl Acad Sci U S A. 2006 Mar 28;103(13):4994-9
pubmed: 16549790
Int J Mol Sci. 2017 Aug 04;18(8):
pubmed: 28777313
PLoS Negl Trop Dis. 2017 Feb 10;11(2):e0005394
pubmed: 28187142
J Mol Microbiol Biotechnol. 2011;21(1-2):71-81
pubmed: 22248544
J Virol. 2019 Feb 5;93(4):
pubmed: 30463967
Emerg Infect Dis. 2015 Dec;21(12):2274-6
pubmed: 26584464
Viruses. 2019 Sep 17;11(9):
pubmed: 31533267
Emerg Infect Dis. 2006 Oct;12(10):1580-3
pubmed: 17176577
PLoS Negl Trop Dis. 2016 Oct 26;10(10):e0005101
pubmed: 27783679
Vector Borne Zoonotic Dis. 2020 Mar;20(3):159-170
pubmed: 31800374
Cell Host Microbe. 2014 Jun 11;15(6):706-16
pubmed: 24922573
Vector Borne Zoonotic Dis. 2013 Feb;13(2):103-10
pubmed: 23249139
Annu Rev Microbiol. 1997;51:151-78
pubmed: 9343347
Am J Trop Med Hyg. 1978 Mar;27(2 Pt 2 Suppl):372-440
pubmed: 646031
PLoS Negl Trop Dis. 2016 Dec 15;10(12):e0005055
pubmed: 27977671
PLoS Pathog. 2013;9(8):e1003591
pubmed: 24009512
Nat Microbiol. 2020 Feb;5(2):239-247
pubmed: 31819213
Viruses. 2015 Nov 11;7(11):5801-12
pubmed: 26569286
J Virol. 1997 Jan;71(1):613-23
pubmed: 8985391
Nature. 2017 Jun 15;546(7658):401-405
pubmed: 28538723
Am J Hyg. 1954 Mar;59(2):157-63
pubmed: 13138582
Viruses. 2014 Nov 11;6(11):4294-313
pubmed: 25393895
Am J Trop Med Hyg. 2007 Aug;77(2):365-70
pubmed: 17690414
PLoS Pathog. 2020 Feb 6;16(2):e1008102
pubmed: 32027727
PLoS Negl Trop Dis. 2016 Jan 25;10(1):e0004402
pubmed: 26807575
Emerg Infect Dis. 2017 Apr;23(4):625-632
pubmed: 28287375
Infect Genet Evol. 2012 Apr;12(3):557-64
pubmed: 22326536
Viruses. 2018 Oct 18;10(10):
pubmed: 30340365
Nucleic Acids Res. 2018 Apr 20;46(7):3657-3670
pubmed: 29361131
Viruses. 2018 Aug 16;10(8):
pubmed: 30115888
PLoS Negl Trop Dis. 2012;6(2):e1477
pubmed: 22389730

Auteurs

Scott C Weaver (SC)

World Reference Center for Emerging Viruses and Arboviruses, University of Texas Medical Branch, Galveston, TX, USA. sweaver@utmb.edu.
Institute for Human Infections and Immunity, University of Texas Medical Branch, Galveston, TX, USA. sweaver@utmb.edu.
Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX, USA. sweaver@utmb.edu.

Naomi L Forrester (NL)

School of Life Sciences, Keele University, Keele, UK.

Jianying Liu (J)

World Reference Center for Emerging Viruses and Arboviruses, University of Texas Medical Branch, Galveston, TX, USA.
Institute for Human Infections and Immunity, University of Texas Medical Branch, Galveston, TX, USA.
Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX, USA.

Nikos Vasilakis (N)

World Reference Center for Emerging Viruses and Arboviruses, University of Texas Medical Branch, Galveston, TX, USA.
Institute for Human Infections and Immunity, University of Texas Medical Branch, Galveston, TX, USA.
Department of Pathology, University of Texas Medical Branch, Galveston, TX, USA.
Center for Biodefense and Emerging Infectious Diseases, University of Texas Medical Branch, Galveston, TX, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH